Dexrazoxane Hydrochloride and Eloctate with Fc Fusion Protein recombinant
Determining the interaction of Dexrazoxane Hydrochloride and Eloctate with Fc Fusion Protein recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Eloctate with Fc Fusion Protein (recombinant), Eloctate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Hydrochloride-Elotuzumab
- Dexrazoxane Hydrochloride-Elotuzumab Intravenous
- Dexrazoxane Hydrochloride-Eloxatin
- Dexrazoxane Hydrochloride-Elppa CoQ10 coenzyme Q-10
- Dexrazoxane Hydrochloride-Elspar
- Dexrazoxane Hydrochloride-Elta SilverGel
- Eloctate with Fc Fusion Protein recombinant-Dexrazoxane Intravenous
- Eloctate with Fc Fusion Protein recombinant-Dextenza Insert
- Eloctate with Fc Fusion Protein recombinant-Dextenza intraocular
- Eloctate with Fc Fusion Protein recombinant-Dextran 40
- Eloctate with Fc Fusion Protein recombinant-Dextran 70 6% in 5% Dextrose high molecular weight
- Eloctate with Fc Fusion Protein recombinant-Dextran 75